HLRCC

Version	Summary	Created by	Modification	Content Size	Created at	Operation
1		Camila Xu	+ 670 word(s)	670	2020-12-15 07:26:40

Cite

If you have any further questions, please contact Encyclopedia Editorial Office.

Select a Style

Xu, C. HLRCC. Encyclopedia. Available online: https://encyclopedia.pub/entry/4081 (accessed on 27 September 2026).

Xu C. HLRCC. Encyclopedia. Available at: https://encyclopedia.pub/entry/4081. Accessed September 27, 2026.

Xu, Camila. "HLRCC" Encyclopedia, https://encyclopedia.pub/entry/4081 (accessed September 27, 2026).

Xu, C. (2020, December 23). HLRCC. In Encyclopedia. https://encyclopedia.pub/entry/4081

Xu, Camila. "HLRCC." Encyclopedia. Web. 23 December, 2020.

HLRCC

Edit

This entry is adapted from the peer-reviewed paper https://medlineplus.gov/genetics/condition/hereditary-leiomyomatosis-and-renal-cell-cancer

Hereditary leiomyomatosis and renal cell cancer (HLRCC) is a disorder in which affected individuals tend to develop benign tumors containing smooth muscle tissue (leiomyomas) in the skin and, in females, the uterus. This condition also increases the risk of kidney cancer.

genetic conditions

References

Adamane S, Desai S, Menon S. Hereditary leiomyomatosis and renal cell cancersyndrome associated renal cell carcinoma. Indian J Pathol Microbiol. 2017Jan-Mar;60(1):108-110. doi: 10.4103/0377-4929.200025.
Adams A, Sharpe KK, Peters P, Freeman M. Hereditary leiomyomatosis and renalcell cancer (HLRCC): cutaneous and renal manifestations requiring amultidisciplinary team approach. BMJ Case Rep. 2017 Apr 11;2017. pii:bcr-2016-215115. doi: 10.1136/bcr-2016-215115.
Arenas Valencia C, Rodríguez López ML, Cardona Barreto AY, Garavito Rodríguez E, Arteaga Díaz CE. Hereditary leiomyomatosis and renal cell cancer syndrome:identification and clinical characterization of a novel mutation in the FH genein a Colombian family. Fam Cancer. 2017 Jan;16(1):117-122. doi:10.1007/s10689-016-9922-4.
Menko FH, Maher ER, Schmidt LS, Middelton LA, Aittomäki K, Tomlinson I,Richard S, Linehan WM. Hereditary leiomyomatosis and renal cell cancer (HLRCC):renal cancer risk, surveillance and treatment. Fam Cancer. 2014 Dec;13(4):637-44.doi: 10.1007/s10689-014-9735-2. Review.
Patel VM, Handler MZ, Schwartz RA, Lambert WC. Hereditary leiomyomatosis andrenal cell cancer syndrome: An update and review. J Am Acad Dermatol. 2017Jul;77(1):149-158. doi: 10.1016/j.jaad.2017.01.023.
Schmidt LS, Linehan WM. Hereditary leiomyomatosis and renal cell carcinoma.Int J Nephrol Renovasc Dis. 2014 Jun 20;7:253-60. doi: 10.2147/IJNRD.S42097.
Teh J, Kinnear N, Douglass-Molloy H, Hennessey DB. Hereditary leiomyomatosisand renal cell cancer syndrome: a family affair. BMJ Case Rep. 2017 Jan 25;2017. pii: bcr2016218270. doi: 10.1136/bcr-2016-218270.
Vocke CD, Ricketts CJ, Merino MJ, Srinivasan R, Metwalli AR, Middelton LA,Peterson J, Yang Y, Linehan WM. Comprehensive genomic and phenotypiccharacterization of germline FH deletion in hereditary leiomyomatosis and renalcell carcinoma. Genes Chromosomes Cancer. 2017 Jun;56(6):484-492. doi:10.1002/gcc.22452.
Wong MH, Tan CS, Lee SC, Yong Y, Ooi AS, Ngeow J, Tan MH. Potential geneticanticipation in hereditary leiomyomatosis-renal cell cancer (HLRCC). Fam Cancer. 2014 Jun;13(2):281-9. doi: 10.1007/s10689-014-9703-x. Review.

©Text is available under the terms and conditions of the Creative Commons-Attribution ShareAlike (CC BY-SA) license; additional terms may apply. By using this site, you agree to the Terms and Conditions and Privacy Policy.

Upload a video for this entry

Information

Subjects: Genetics & Heredity

Contributor MDPI registered users' name will be linked to their SciProfiles pages. To register with us, please refer to https://encyclopedia.pub/register : Camila Xu

View Times: 849

Entry Collection: MedlinePlus

Update Date: 23 Dec 2020

Table of Contents

Video Upload Options

References